Da Hee Han


All articles by Da Hee Han

Custom drug update image

First Rituximab Biosimilar Truxima Gets FDA Approval

The FDA approval was supported by clinical data describing structural and functional characterization, preclinical data, human pharmacokinetic data, clinical immunogenicity data, and other data which showed no clinically meaningful differences between Truxima and Rituxan.

Next post in Medicine